中国实用外科杂志 ›› 2010, Vol. 30 ›› Issue (09): 754-756.

• 专题笔谈 • 上一篇    下一篇

胰腺血管活性肠肽瘤临床特点和诊治

孙    备,李    鹏   

  1. 哈尔滨医科大学附属第一医院胰胆外科,黑龙江哈尔滨 150001
  • 出版日期:2010-09-01 发布日期:2010-09-01

  • Online:2010-09-01 Published:2010-09-01

摘要:

胰腺血管活性肠肽瘤(vasoactive intestinal peptide tumors,VlPoma)为罕见的胰腺内分泌肿瘤,有典型的临床表现,如水样腹泻、低钾血症、胃酸缺乏。胰体尾部是病变的主要部位。临床筛查,早期诊断,恰当的处理方式,可影响病人的存活率并提高生存质量。典型症状和血浆血管活性肠肽(vasoactive intestinal polypeptide,VIP)值是诊断的关键。手术切除是最佳的治疗方式。药物治疗首选生长抑素类似物,可以使疾病症状(即使是未行手术者)长期缓解。

Abstract:

Clinical manifestations,diagnosis and treatment of pancreatic VIPoma        SUN Bei,LI Peng. The First Affiliated Hospital of Harbin Medical University, Harbin150001,China
Corresponding author:SUN Bei,E-mail: sunbei70@tom.com
Abstract    VIPomas (vasoactive intestinal peptide tumors) are rare pancreatic endocrine tumors associated with a well-defined clinical syndrome characterized by watery diarrhea , hypokalemia and achlorhydria. The pancreatic body and tail were the main locations of lesions. Clinical screening, early diagnosis and precise management may affect survival and improve the quality of life of patients. Typical symptoms and the plasma value of VIP(vasoactive intestinal polypeptide) were keys to diagnosis. The resection of operation is the most effective means for treatment. The first choice of medication is somatostatin analogs which can induce long-term remission even in inoperable lesions.